Dallah Healthcare CoSAU:4004 +1.09%92 Median PS Value is ﷼187.05 as of Jul. 02, 2026, which is 100% below its 10-year median of 1.02. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼205.07 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 263 Healthcare Providers & Services companies, Dallah Healthcare Co ranks better than 60.08% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Dallah Healthcare Co's Median PS Value or its related term are showing as below:
SAU:4004'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.59 Med: 1.02 Max: 1.34
Current: 0.59
During the past 13 years, the highest Price to Median PS Value of Dallah Healthcare Co was 1.34. The lowest was 0.59. And the median was 1.02.
SAU:4004's Price-to-Median-PS-Value is ranked better than 60.08% of 263
companies
in the Healthcare Providers & Services industry
Industry Median: 0.7
vs SAU:4004: 0.59
Dallah Healthcare Co (SAU:4004) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Dallah Healthcare Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
111.00
/
187.05
=
0.59
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co Median PS Value Related Terms
Dallah Healthcare Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 4.4943.
Dallah Healthcare Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼41.619.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a Median PS Value of ﷼187.05 as of Jul. 02, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Dallah Healthcare Co and its competitors. This is 18238% above median its historical median of 1.02. Over the past decade, Dallah Healthcare Co's Median PS Value has ranged from 0.59 to 1.34. According to the industry distribution chart, Dallah Healthcare Co ranks #105 out of 263 companies in the Healthcare Providers & Services industry, placing it in the top 39.9%.
Is Dallah Healthcare Co's Median PS Value too high?
Dallah Healthcare Co's current Median PS Value of ﷼187.05 is 18238% above median its 10-year median of 1.02. Over the past 10 years, this metric has ranged from a low of 0.59 to a high of 1.34. Based on the distribution chart, Dallah Healthcare Co ranks #105 out of 263 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #105 out of 263 companies for Median PS Value. This puts Dallah Healthcare Co in the upper half of its industry. The industry median Median PS Value is 0.70. Historically, Dallah Healthcare Co's own Median PS Value has ranged from 0.59 to 1.34 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.70, based on 263 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current Median PS Value is ﷼187.05, which is 18238% above median its own 10-year median of 1.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼205.07, compared to a current price of ﷼111.00 — trading 45.9% below its estimated fair value. The current Median PS Value is ﷼187.05, which is 18238% above median its 10-year median of 1.02. Dallah Healthcare Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Median PS Value is ﷼187.05 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼111.00 is trading 45.9% below its estimated GF Value™ of ﷼205.07.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
Median PS Value: ﷼187.05 (18238% above median its 10-year median of 1.02)
GF Value™: ﷼205.07 vs. price of ﷼111.00 (45.9% below fair value)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score
Get the complete analysis for SAU:4004
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
